CryoFuture, a fertility specimen storage and transportation company, has announced a strategic investment from Liss Capital Partners, a Chicago-based family office-backed investment firm. The companies did not disclose the investment amount.
The San Mateo-based company operates seven fertility-dedicated storage facilities across the United States and provides cryogenic transportation services for IVF clinics and patients. CryoFuture was founded by senior embryologist Sean Pae and healthcare executive Cherie Kloss.
“Safe, secure, and convenient long-term cryopreservation is essential for IVF clinics and patients, and we are proud to lead with the most comprehensive suite of services,” said Sean Pae, Founder and CEO of CryoFuture. “The Liss Capital partnership validates the progress we’ve made in bringing local, long-term storage solutions to fertility clinics and patients across the U.S. and enables us to scale responsibly while continuing to deliver the white-glove service the IVF community deserves.”
“CryoFuture is redefining the way fertility specimens are safeguarded in the U.S. Its infrastructure, technology, and service model set a new benchmark for mission-critical cryopreservation,” said Cameron Liss, Co-Managing Partner of Liss Capital Partners. “We are proud to partner with a category leader and look forward to helping accelerate CryoFuture’s continued expansion as clinics and patients increasingly seek safer, more transparent, and more reliable solutions.”
The company said the investment will support national expansion and continued investment in its cryopreservation technology and services.
